Mandate

Vinge advises in Stendörren’s issuance of senior unsecured bonds

November 11, 2021 Banking and Finance

Vinge advises in Stendörren Fastigheter AB’s issuance of a new senior unsecured bond in an amount of SEK 600,000,000 within a framework amount of SEK 1,200,000,000.

The new bonds have a tenor of 3.75 years and carries a floating rate interest of 3 months STIBOR plus 390 basis points. In accordance with the terms and conditions, the new bonds are intended to be listed on the corporate bond list of Nasdaq Stockholm. Danske Bank A/S, Danmark, Sverige Filial and Skandinaviska Enskilda Banken AB (publ) acted as arrangers and joint bookrunners in connection with the transaction. Danske Bank A/S, Danmark, Sverige Filial also acted as issuing agent.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Benjamin Vafaeian.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026